Clinical Trials Logo

Filter by:
NCT ID: NCT02766829 Completed - Clinical trials for Adult Patients With Spinal Anesthesia

Comparison of Successful Spinal Needle Placement Between Crossed Leg Sitting Position and Traditional Sitting Position

Start date: March 2015
Phase: N/A
Study type: Interventional

The study aimed to compare successful spinal needle placement between crossed leg sitting position and traditional sitting position in patients underwent urology surgery.

NCT ID: NCT02763462 Completed - Clinical trials for Acute Febrile Illness

The Etiology of Acute Febrile Illness Requiring Hospitalization

AFIRE
Start date: July 2013
Phase:
Study type: Observational

This study is an observational cohort study of hospitalized patients with fever. This study will collect demographic data, history of illness, signs and symptoms, results of laboratory tests, clinical course, treatment and outcome. This study conducted at eight INA-RESPOND hospitals. Potential study patients will be any patients (both children and adults).

NCT ID: NCT02758236 Completed - MDR TB Clinical Trials

Tuberculosis Research of INA-RESPOND On Drug Resistance

TRIPOD
Start date: February 13, 2017
Phase:
Study type: Observational

This study is a prospective observational cohort study of TB patients who are treated or evaluated at 10 study sites. Patients presenting with cough for 2 weeks or longer with at least one additional TB symptom and a chest X-ray suggestive of TB, will be invited to be enrolled in the study. The signed informed consent will designate their willingness to participate on this study.

NCT ID: NCT02754531 Completed - General Anesthesia Clinical Trials

Ultrasonography vs Cole Formula to Predict Endotracheal Tube Diameter

Start date: May 2016
Phase: N/A
Study type: Interventional

This study aims to compare the accuracy of measurement between ultrasonography and Cole formula in predicting uncuffed endotracheal tube diameter.

NCT ID: NCT02700490 Completed - Mental Disorders Clinical Trials

Evaluating the Clinical Cost-effectiveness of Two Primary Mental Health Service Frameworks in Yogyakarta, Indonesia

Start date: December 2016
Phase: N/A
Study type: Interventional

This study is a cluster randomised controlled trial, which aims to examine the short-term strategy of addressing treatment gap through increasing primary mental health service capacity. This study aims to compare after 6 months and 12 months, the effectiveness of a specialist model of mental health care and an enhanced usual care (task-sharing) framework, in terms of reducing mental health symptoms, reducing disability, and improving quality of life, as well as the health services costs (and potentially societal costs) associated with these outcomes in 400 patients.

NCT ID: NCT02660060 Completed - Healthy Clinical Trials

Bioequivalence Study of Two Formulations of Pramipexole Tablets 0.25 mg

Start date: May 2015
Phase: N/A
Study type: Interventional

The present study was conducted to find out whether the bioavailability of 0.25 mg pramipexole tablets produced by PT Dexa Medica for PT Ferron Par Pharmaceuticals was equivalent to the reference drug (Sifrol® tablet 0.25 mg, Boehringer Ingelheim Pharma GmbH & Co. KG, Germany for Boehringer Ingelheim International GmbH, Germany).

NCT ID: NCT02608073 Completed - Clinical trials for Nasopharyngeal Cancer

A Study of Capecitabine (Xeloda) as First-Line Chemotherapy in Participants With Metastatic Nasopharyngeal Cancer

Start date: November 2004
Phase: Phase 2
Study type: Interventional

This study will evaluate the efficacy, safety, tolerability, and effect on quality of life of oral capecitabine in combination with intravenous (IV) cisplatin in participants with metastatic nasopharyngeal cancer. Participants will receive up to 8 cycles of capecitabine treatment, and cisplatin will be administered on the first day of each cycle. The anticipated time on study treatment is up to 24 weeks, and the target sample size is 44 individuals.

NCT ID: NCT02592109 Completed - Overweight Clinical Trials

Effect of Enhanced Counseling Using Complementary Feeding Recommendation Based on Linear Programming on Nutritional Status,Omega-3 Fatty Acids, Malondialdehyde, and Alpha-Tocopherol in Overweight Children in East Jakarta

Start date: November 2015
Phase: Phase 2
Study type: Interventional

The epidemic of pediatric obesity has become a public health burden in both developed and developing countries, due to its serious health consequences, including an increased risk of type 2 Diabetes Mellitus and heart disease. Currently, dietary and exercise changes are still the center of preventive and treatment measures of obesity. Recently, the omega-3 group, one of the groups of polyunsaturated fatty acids (PUFAs), has been associated with many positive effects leading to the improvement of many diseases related to obesity. Nevertheless, the consumption of this essential nutrient requires certain ration to optimize its favorable result. Although previous studies have examined the efficacy of dietary counseling approach as treatment for obesity, none of them as explicitly explore the use of linear programming to create a tailored diet containing high omega-3 fatty acid food as a part of dietary counseling in obesity management program among children. Thus, this study is intended to contribute the clinical evidence regarding this area of knowledge, specifically the effects of enhanced counseling containing complementary feeding recommendation on nutritional status, omega-3 fatty acid, malondialdehyde, and alpha Tocopherol among children with risk of overweight aged 12 -23 months in East Jakarta.

NCT ID: NCT02521168 Completed - Clinical trials for Postoperative; Dysfunction Following Cardiac Surgery

Oral Triiodothyronine for Children Undergoing Cardiopulmonary Bypass in Indonesia

OTICC
Start date: July 2013
Phase: Phase 3
Study type: Interventional

A condition of decreased serum T3 level in children after cardiac surgery using cardiopulmonary bypass has been commonly recognized as euthyroid sick syndrome (ESS). This syndrome has been closely associated with low cardiac output syndrome after heart surgery. The unique characteristics of pediatric patients with congenital heart disease (CHD) in Indonesia have caused ESS to arise in the population even before surgical managements. Thyroid hormones increase cardiac function, respiration and diuresis. Increased myocardial function occurred through the improvement of mitochondrial effectiveness as the body energy source by utilizing effective energy substrates, lactate and pyruvate. Prevention of decreased serum thyroid hormones level by T3 supplementation could be clinically beneficial. Intravenous T3 unit dose is very expensive and inapplicable for daily use. In adult studies, oral T3 was found to be effective for the prevention of decreased serum T3 levels; similar study on pediatric population, however, has not been elucidated.

NCT ID: NCT02518451 Completed - Healthy Clinical Trials

Bioequivalence Evaluation of Two Film-Coated Formulations of Valsartan 160 mg

Start date: June 2013
Phase: N/A
Study type: Interventional

This was a randomized, single-blind, two-period, two sequence cross-over study under fasting condition, with a one-week wash-out period, to compare the pharmacokinetic profiles and bioavailability of two formulations (the test and reference) of valsartan 160 mg film-coated caplets.